UMB Bank’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.5K | Sell |
441
-2
| -0.5% | -$48 | ﹤0.01% | 1586 |
|
|
2025
Q1 | $11K | Buy |
443
+66
| +18% | +$1.64K | ﹤0.01% | 1516 |
|
|
2024
Q4 | $7.1K | Buy |
377
+74
| +24% | +$1.39K | ﹤0.01% | 1591 |
|
|
2024
Q3 | $4.56K | Sell |
303
-72
| -19% | -$1.08K | ﹤0.01% | 1760 |
|
|
2024
Q2 | $10.7K | Buy |
375
+31
| +9% | +$887 | ﹤0.01% | 1253 |
|
|
2024
Q1 | $10.1K | Buy |
344
+20
| +6% | +$584 | ﹤0.01% | 1275 |
|
|
2023
Q4 | $10.9K | Sell |
324
-272
| -46% | -$9.18K | ﹤0.01% | 1263 |
|
|
2023
Q3 | $18.3K | Hold |
596
| – | – | ﹤0.01% | 1108 |
|
|
2023
Q2 | $23.9K | Hold |
596
| – | – | ﹤0.01% | 1051 |
|
|
2023
Q1 | $24.3K | Hold |
596
| – | – | ﹤0.01% | 1035 |
|
|
2022
Q4 | $23K | Hold |
596
| – | – | ﹤0.01% | 1073 |
|
|
2022
Q3 | $32K | Buy |
596
+30
| +5% | +$1.61K | ﹤0.01% | 976 |
|
|
2022
Q2 | $33K | Hold |
566
| – | – | ﹤0.01% | 1017 |
|
|
2022
Q1 | $43K | Buy |
566
+149
| +36% | +$11.3K | ﹤0.01% | 1010 |
|
|
2021
Q4 | $25K | Buy |
+417
| New | +$25K | ﹤0.01% | 1206 |
|